Finding the CB3 Receptor Could a Medical Breakthrough

Matt Weeks May 28, 2018 1 comment

A fairly recent discovery — the CB3 receptor — could go a long way towards unlocking the unexplained mysteries of cannabis.

Originally called GPR55 after the gene that encodes it, the CB3 receptor has been up-ending expectations since researchers found it. Every new finding provides more explanations about the mechanisms by which cannabis works within the body.

The CB3 stayed stayed hidden from scientists because it’s so unlike the other cannabinoid receptors. It only shares fourteen percent of amino acid identity with them. It simply doesn’t look like it would react with cannabis, so scientists on the hunt for new receptors passed over it for years.

Even after it was discovered in 1999, many doubted it was a cannabis receptor. It wasn’t until real proof came along years later (finally confirmed through a 2008 study published in the journal PNAS) that medical researchers accepted that GPR55 was actually CB3.[1]Lauckner, Jane E. et al. (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. PNAS. 105(7) 2699-2704.

Now, more recent research on the CB3 receptor is ushering in an era of new possibilities that may finally explain the unsolved mysteries of cannabis medicine.

[bsa_pro_ad_space id=25]

A Closer Look at the CB3 Receptor

The CB3 receptor is a G-protein coupler receptor that is scattered throughout the body, but concentrated in the brain and guts. It is most densely packed in the brain’s cerebellum region, which controls the body’s motor functions, such as walking and speech.

Once it was discovered, scientists had to figure out what the GPR55 receptor did. Early research sponsored by companies like Astra Zeneca and Glaxo Smith Kline focused on GPR55 as a possible mechanism by which to control blood pressure.

Slowly but surely, researchers began to see GPR55 as a true cannabinoid receptor. A study published in the British Journal of Pharmacology (2007) found that several cannabinoids, including CBD, could potentially bind to GPR55.[2]Ryberg, E. et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology. 152(7) 1092-1101.

Confirming CB3

But it wasn’t until the 2008 PNAS study that scientists learned what actually happens when a cannabinoid interacts with GPR55. When THC enters the body and meets a CB3 receptor, it increases intracellular calcium and inhibits the M current in the brain. While the full ramifications of these findings are not clear, they are the first steps toward understanding how the CB3 receptors influence changes in the body and mind.[3]Lauckner, Jane E. et al. (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. PNAS. 105(7) 2699-2704.

[bsa_pro_ad_space id=26]

Central Nervous System 3D animation, this is where cb3 receptors are

Further Research

Building off that research, a 2017 study published in cancer journal Oncotarget showed, beyond all doubt, that GPR55 expression correlates strongly with the cancer cells that are about to metastasize. In other words, it’s kind of like the canary in the coal mine of cancer spreading.[4]Mangini M. et al. (2017). Peptide-guided targeting of GPR55 for anti-cancer therapy. Oncotarget. 8(3) 5179-5195.

Scientists reasoned that if CB3 receptors could be manipulated — most probably by cannabinoids — they might be able to stop the spread of cancer by killing their signaling device. Or, to put it another way, the scientists may now know where to look in deciphering the potential anti-cancer effects of cannabis.

RELATED  Opioids Versus Cannabis For Nerve Pain

Beyond Cancer

While some scientists were busy trying to unlock the mysteries of cannabis and cancer by exploring the CB3 receptor, others saw its potential to explain yet another puzzle: the relationship between cannabis and epilepsy.

It’s long been shown that cannabis can have anti-seizure properties. The first cannabis-based drug approved by the American FDA is currently in use to treat epilepsy. Scores of seizure sufferers have found their lives transformed by just a few drops of cannabis or by smoking a single joint.

But despite the preponderance of evidence, there’s still not a satisfying explanation for why cannabis has such powerful anti-seizure properties. The CB3 receptor in the part of the brain responsible for motor functioning seemed like a smart bet.

In 2017, a group of scientists publishing in the journal PNAS, broke the concept wide open. It was already confirmed that CBD reduced the frequency of, and severity of, seizures in patients with Dravet Syndrome, a rare childhood form of epilepsy. But the new study went a step further in explaining just how it worked.[5]Kaplan, Jonathan H. (2017). Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. PNAS. 114 (42) 11229-11234.

Dravet Syndrome

The scientists discovered that all those symptoms of Dravet Syndrome — as well as the autistic-like social deficits that often accompany the disease — are mediated by CBD in part through the CB3 receptor.

A Dravet Syndrome patient, Charlotte Figi, galvanized American support of medicinal cannabis. It came through CNN’s 2003 documentary “Weed.”

The film shows how when patients take CBD, the brain undergoes a crucial change. This change, which prevents the seizures and asocial effects the disorder creates, has long been mysterious. But the research shows that CBD activates the CB3 receptor, which in turn inhibited neurotransmissions responsible for Dravet Syndrome effects.

THC binding to CB1 Receptor, like it may to CB3 receptor

The Next Steps

The excitement over a confirmed new kind of cannabinoid receptor in the brain and guts is not just good news for cannabis-based medicine. It’s good news for all kinds of medicine.

RELATED  Is The Western Diet Damaging The Endocannabinoid System?

As scientists better understand the full scope and function of the human endocannabinoid system, they are closer to understanding a vital and multifaceted component of the central nervous system. The more medicine understands this system, the better it will be able to treat all diseases and disorder — whether it’s through cannabis-based treatments or not.

Other Ways to Activate CB3?

More than just cannabinoids activate the CB3 receptor. There are also other lipids and peptides that work with and through it to produce changes in the body’s neurochemistry. Advances in these areas could prove just as important as new cannabinoid-based discoveries.

The bulk of new information is likely to explain the behavioral, vascular, and immunological functions of cannabis in the body. What new treatments this will lead to is anyone’s guess, but a new avenue for explanation offers a lot to be excited about.


Author avatar

Matt Weeks

A writer living and working in Athens, GA, Matt's work has appeared in various newspapers, books, magazines and online publications over the last 15 years. When he's not writing, he hosts bar trivia, plays in local bands, and makes a mean guacamole. He holds an undergraduate degree in journalism and a master's degree in organizational theory. His favorite movie is "Fletch."

1 comment

  1. Avatar

    Jenn Williams

    Great find in learning of a new cb receptor and the potential of learning how to fight cancer!

Post a comment

Your email address will not be published. Required fields are marked *

Click to Hide Advanced Floating Content